Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D01APZ
|
||||
Former ID |
DNC011571
|
||||
Drug Name |
(D)Arg-Arg-Pro-Hyp-Gly-Thi-Cys-(D)Phe-Phe-Cys-Arg
|
||||
Indication | Discovery agent | Investigative | [529475] | ||
Structure |
Download2D MOL |
||||
Formula |
C61H88N20O13S3
|
||||
Canonical SMILES |
C1CC(N(C1)C(=O)C(CCCN=C(N)N)NC(=O)C(CCCN=C(N)N)N)C(=O)N<br />2CC(CC2C(=O)NCC(=O)NC(CC3=CC=CS3)C(=O)NC4CSSCC(NC(=O)C(<br />NC(=O)C(NC4=O)CC5=CC=CC=C5)CC6=CC=CC=C6)C(=O)NC(CCCN=C(<br />N)N)C(=O)O)O
|
||||
InChI |
1S/C61H88N20O13S3/c62-38(17-7-21-69-59(63)64)49(84)74-39(18-8-22-70-60(65)66)56(91)80-24-10-20-46(80)57(92)81-31-36(82)28-47(81)55(90)72-30-48(83)73-43(29-37-16-11-25-95-37)52(87)79-45-33-97-96-32-44(53(88)75-40(58(93)94)19-9-23-71-61(67)68)78-51(86)42(27-35-14-5-2-6-15-35)76-50(85)41(77-54(45)89)26-34-12-3-1-4-13-34/h1-6,11-16,25,36,38-47,82H,7-10,17-24,26-33,62H2,(H,72,90)(H,73,83)(H,74,84)(H,75,88)(H,76,85)(H,77,89)(H,78,86)(H,79,87)(H,93,94)(H4,63,64,69)(H4,65,66,70)(H4,67,68,71)/t36?,38-,39-,40?,41-,42?,43?,44?,45-,46-,47-/m1/s1
|
||||
InChIKey |
QRPRDXXCSGEGJN-AAAINLOGSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | B2 bradykinin receptor | Target Info | Inhibitor | [529475] | |
KEGG Pathway | Calcium signaling pathway | ||||
cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Complement and coagulation cascades | |||||
Inflammatory mediator regulation of TRP channels | |||||
Regulation of actin cytoskeleton | |||||
Endocrine and other factor-regulated calcium reabsorption | |||||
Chagas disease (American trypanosomiasis) | |||||
Pathways in cancer | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Direct p53 effectors | ||||
Validated transcriptional targets of deltaNp63 isoforms | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.